Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Net Income Margin

Rigel Pharmaceuticals Net Income Margin Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Net Income Margin from 2010 to 2020. Net profit margin, or net margin, is equal to net income or profits divided by total revenue and represents how much profit each dollar of sales generates. Net profit margin is the ratio of net profits or net income to revenues for a company.
  • Rigel Pharmaceuticals Net Income Margin for the quarter ending September 09, 2020 was $-77m a -44.90% increase of 35m year over year
  • Rigel Pharmaceuticals Net Income Margin for the last 12 months ending September 09, 2020 was $-26m a -329.91% increase of 87m year over year
  • Rigel Pharmaceuticals Annual Net Income Margin for 2019 was $-113m a -40.35% increase of 46m from 2018
  • Rigel Pharmaceuticals Annual Net Income Margin for 2018 was $-158m a -998.42% increase of 1,581m from 2017
  • Rigel Pharmaceuticals Annual Net Income Margin for 2017 was $-1,739m a 80.48% decrease of -1,400m from 2016
Other Margins & Efficiency Metrics:
  • Rigel Pharmaceuticals EBITDA Margin for the quarter ending December 12, 2018 was $7m a 801.93% increase of 57m year over year
  • Rigel Pharmaceuticals Return on Capital % for the quarter ending September 09, 2018 was -53.67 a -55.75% increase of 29.92 year over year
  • Rigel Pharmaceuticals Return on Equity % for the quarter ending September 09, 2018 was -83.74 a -57.61% increase of 48.24 year over year
View Chart On Koyfin

Quarterly RIGL Net Income Margin Data

09/2020$-77m
06/2020$-110m
03/2020$38m
12/2019$-112m
09/2019$-55m
06/2019$-198m
03/2019$-139m
12/2018$9m
09/2018$-489m
06/2018$-1,430m

Annual RIGL Net Income Margin Data

2019$-113m
2018$-158m
2017$-1,739m
2016$-340m
2015$-178m
2014$-1,102m
2013$-1,245m
2012$-4,393m
2011$-1,810m
2010$30m